PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Frost & Sullivan Honours AESKU.SYSTEMS for Developing a Fast and Economic Diagnostic Automation Tool for Autoimmune Diseases - AESKU.SYSTEMS has outstripped competition in the autoimmunity market with 240 HELMED® system installations within a short span of two years
Frost & Sullivan Honours AESKU.SYSTEMS for Developing a Fast and Economic Diagnostic Automation Tool for Autoimmune Diseases

 

NewswireToday - /newswire/ - London, United Kingdom, 2012/03/27 - AESKU.SYSTEMS has outstripped competition in the autoimmunity market with 240 HELMED® system installations within a short span of two years.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Based on its recent analysis of the autoimmune diagnostics market, Frost & Sullivan recognizes AESKU.SYSTEMS GmbH & Co. KG with the 2011 Europe Frost & Sullivan Product Differentiation Excellence of the Year Award. AESKU.SYSTEMS' extensive research capabilities and instrumentation expertise has culminated in the successful HELMED® analyser. HELMED® is a fully automated and open immunofluorescence processor capable of performing all IFA methods. It is suitable for Autoimmunity (room temperature) and it is the only system in the market that can process Infectious Serology slides (up to 40oC).

HELMED® was one of the first systems in the market to include as a standard built-in bar code reader ensuring correct traceability of patient IDs. As the system is automated, it reduces operator hands on time and eliminates reproducibility errors and inter/intra-lab variations. HELMED® can accommodate 20 slides, four different tests and up to 150 samples per run, which results in higher throughput than its nearest competitors. HELMED® brings standardization to the lab: no matter who operates the system the results from automatic processing are always consistent. No IFA expertise is required to operate the instrument thus improving the resources in the lab where the IFA expert can just focus on what really matters: interpretation of the results.

"HELMED® can be easily programmed to process almost any slide regardless of the manufacturer, for both autoimmunity and infectious serology procedures," said Frost & Sullivan Research Analyst Srinivas Sashidhar. "It can be connected to user-friendly IFA data management software called HELPS+®, which offers an easy way to digitize all IFA results, adding traceability to the results as well as real images from the microscope. The HELPS+® interface allows the user to compare the live view with the image library provided by Aesku, which also includes an IFA pattern library and associated diseases knowledge database."

Uniquely, HELMED® can directly accommodate different types of sample tubes and optimise different sample conditions according to the needs of the test protocols. It was also the first processor to include a built-in bar code reader to ensure traceability of the sample.

One of HELMED®'s outstanding features is its ease-of-use. The processor is fully automated and packaged with in-built software, which is pre-programmed for different tests. AESKU.SYSTEMS' product can complete a full run with a mean time of 2.5 hours, making it faster than the competing products. Its three needle design and independent ring architecture ensures fast processing whilst eliminating unnecessary arm movements which makes the system even more robust.

HELMED® HTC is a special edition with a unique designed; it does not only control the temperature but also the humidity in the chamber thus eliminating the risk of sample evaporation."

AESKU.SYSTEMS' products are International Standards Organisation (ISO)-certified, evidencing the company's strong commitment to reliability, practicability and efficiency. HELMED® is also Conformité Européene (CE)-marked and Food and Drug Administration (FDA)-approved.

Each year, Frost & Sullivan presents this award to the company that demonstrates superior features and functionality as well as quality and complexity. The company also exhibits high levels of customization, excellent product mix and meet the requirements of its target market.

Frost & Sullivan Best Practices awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis and extensive secondary research to identify best practices in the industry.

About AESKU
AESKU is a group of companies, based in Wendelsheim, Germany, focusing on the research, development and production of innovative and high quality products and services for the early detection, diagnosis and prognosis of autoimmune diseases.

AESKU SYSTEMS is the instrumentation branch, with the mission to develop and produce pioneering automation solutions for the unique IVD products coming from the research pipeline of AESKU DIAGNOSTICS. The aim is to develop easy-to-use instruments which standardize the processing thus eliminate human error and variations, for a faster and more reliable diagnosing.

A multidisciplinary team of engineers, chemists and laboratory technicians are responsible for compiling ideas and input from consultants, end-users, and the AESKU R&D teams; merging these ideas with the finest standards in automation & latest technologies, in order to develop instruments that fit the needs, reality and expectations of the clinical laboratory.

About Frost & Sullivan
Frost & Sullivan (frost.com), the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages 50 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 40 offices on six continents.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Frost & Sullivan

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Medical Services/Equipment articles,
CATCH Visitors via Your Competitors Announcements!


Frost & Sullivan Honours AESKU.SYSTEMS for Developing a Fast and Economic Diagnostic Automation Tool for Autoimmune Diseases

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Catherine Brassell 
+27(0)21 680 3267 catherine.brassell[.]frost.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Medical Services/Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Frost & Sullivan / Company Profile


Read Medical Services/Equipment Most Recent Related Newswires:

Frost & Sullivan Recognizes Ventec Life Systems for New Product Innovation - Game-changing, Modular Respiratory System, VOCSN
BD Expands Genomics Portfolio with New Single Cell Platform for RNA Expression Analysis
GE Healthcare Advances the Delivery of Cell Therapies with New Thawing Technology
Ansell Limited Announces the Closing of the Sale of its Sexual Wellness Business
PQ Bypass Earns Frost & Sullivan’s European Technology Innovation Award for its Proprietary DETOUR System for Percutaneous Bypass
Curaçao EMS Uses ZOLL Autopulse to Save Tourist in Sudden Cardiac Arrest
ZOLL to Showcase Expanded Portfolio of AEDs at Caravan Salon 2017
MDxHealth Announces Service Agreement with Kaiser Southern California Permanente Medical Group
Frost & Sullivan Lauds CytoSorbents for Leading the Critical Care Immunotherapy Segment with its Novel Blood Purification Solution, CytoSorb®
MVZ Dr. Stein & Kollegen First German Medical Laboratory to Offer the SelectMDx for Prostate Cancer Test
Datalogic Announces New Healthcare Memor X3 HC Mobile Computer
Neuronix Ltd Announces the First Group of Mild to Moderate Alzheimer Patients to be Successfully Treated by The NeuroAD™ Therapy System
SelectMDx to be Distributed Across Middle East by IPS Genomix
GE Healthcare Partners with Oritain to Introduce Independent Test to Confirm Country of Origin of Fetal Bovine Serum
Saebo, Inc. Awarded Patent for Low-Profile Stroke Recovery Glove

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  NAKIVO, Inc.

Visit  BizJobs.com





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)